상세 보기
Multicenter Prospective Phase II Study of Rituximab Combined, Bortezomib, Lenalidomide, Dexamethasone Followed By Lenalidomide Maintenance (R-VRD) in Patients with Waldenstrom's Macroglobulinemia (KMM1803)
- Lee, Ho Sup;
- Kim, Dajung;
- Jung, Sung-Hoon;
- Lee, Je-Jung;
- Kim, Kihyun;
- ... Lee, Gyeong Won;
- 외 8명
Citations
WEB OF SCIENCE
0- 제목
- Multicenter Prospective Phase II Study of Rituximab Combined, Bortezomib, Lenalidomide, Dexamethasone Followed By Lenalidomide Maintenance (R-VRD) in Patients with Waldenstrom's Macroglobulinemia (KMM1803)
- 저자
- Lee, Ho Sup; Kim, Dajung; Jung, Sung-Hoon; Lee, Je-Jung; Kim, Kihyun; Min, Chang-Ki; Lee, Jae Hoon; Lee, Won-Sik; Lee, JiHyun; Lee, Gyeong Won; Kim, Min Kyoung; Shin, Ho-Jin; Kim, Hyo Jung; Yi, Jun Ho
- 발행일
- 2023-11
- 유형
- Meeting Abstract
- 저널명
- Blood
- 권
- 142
- 언어
- ENG
- 출판사
- American Society of Hematology
- 발행국가
- 미국
- ISSN
- E 1528-0020
P 0006-4971